Surgical coronary revascularization in patients with COVID-19; complications and outcomes: A retrospective cohort

Aryan Ayati1,2, Kaveh Hosseini1, Alireza Hadizadeh2

  • 1Tehran Heart Center Research Institute, Tehran Heart Center Tehran University of Medical Sciences Tehran Iran.

Health Science Reports
|August 12, 2022
PubMed

Insights

Coronary artery bypass grafting (CABG) in COVID-19 patients leads to longer hospital and ICU stays, increased ventilation time, and more postoperative complications. While mortality was higher, it was not statistically significant.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Coronary artery disease (CAD) is a significant comorbidity in COVID-19 patients.
  • Nonelective coronary artery revascularization, including CABG, poses substantial risks for individuals with COVID-19.
  • Understanding risk factors and outcomes is crucial for managing these high-risk patients.

Purpose of the Study:

  • To evaluate the prognosis of coronary artery bypass grafting (CABG) surgery in patients diagnosed with COVID-19.
  • To compare outcomes and complications between COVID-19 positive and negative patients undergoing urgent/emergent CABG.

Main Methods:

  • A retrospective cohort study involving 171 patients who underwent urgent/emergent CABG between March 2020 and September 2021.
  • Patients were categorized into COVID-19 positive (Case) and COVID-19 negative (Control) groups.
  • Demographic, clinical features, complications, and outcomes were compared between the two groups.

Main Results:

  • The COVID-19 group (62 patients) showed a higher prevalence of hypertension (64.5% vs. 43.1%).
  • Significantly longer hospital stays, ventilation times, and ICU stays were observed in COVID-19 patients.
  • Postoperative complications such as stroke, atrial fibrillation, pleural effusion, blood transfusion, and inotrope use were more frequent in the COVID-19 group. Mortality rates were higher but not statistically significant (OR 1.53, p=0.44).

Conclusions:

  • COVID-19 infection is associated with significantly prolonged hospital stays, ventilation, and ICU utilization post-CABG.
  • Patients with COVID-19 undergoing CABG experience a higher incidence of various postoperative complications.
  • Although mortality rates were elevated in COVID-19 patients, the difference did not reach statistical significance in this cohort.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
23
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
24
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
28
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
40
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31